US drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The significant presence of major pharmaceutical companies such as Pfizer Inc., AbbVie Inc., Eli Lilly & co., and others coupled with significant adoption of analytics solutions further provides a significant opportunity to the market. Moreover, the growing research for personalized medicine in the country is encouraging the demand for drug discovery analytics among pharmaceutical companies in the country. The US FDA had received a significant number of applications relating to the approval of personalized medicines over the past years.
To Request a Sample of our Report on US Drug Discovery Informatics Market: https://www.omrglobal.com/request-sample/us-drug-discovery-informatics-market
The Personalized Medicine Coalition has classified 28% of new molecular entities (NMEs) as personalized medicines in 2015, and 42% in 2018, in the US. The growing FDA approvals signify the considerable existence of researches working towards the development of personalized medicine. Personalized medicine formation requires patient-specific data to create therapeutic strategies for individual patients. In the overall process of personalized medicine formation, a large amount of data gets generated which when analyzed have the potential to enable the diagnosis, treatment, and prevention of disease at a highly personalized level. Therefore, an increase in the number of researches related to the development of personalized medicine in the country is making a considerable scope for the US drug discovery informatics market.
(Get 15% Discount on Buying this Report)
A full Report of US Drug Discovery Informatics Market is Available at: https://www.omrglobal.com/industry-reports/us-drug-discovery-informatics-market
US Drug Discovery Informatics Market – Segmentation
By Function
- Docking
- Molecular Modeling
- Libraries and Database Preparation
- Sequencing and Target Data Analysis
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CRO)
- Others (Research Institutes)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
